109 related articles for article (PubMed ID: 7505847)
1. [HEPT and its related compounds as anti-HIV agents].
Miyasaka T; Tanaka H; Baba M
Nihon Rinsho; 1993 Sep; 51 Suppl():200-6. PubMed ID: 7505847
[No Abstract] [Full Text] [Related]
2. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
[TBL] [Abstract][Full Text] [Related]
3. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
Kireev DB; Chrétien JR; Grierson DS; Monneret C
J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
[TBL] [Abstract][Full Text] [Related]
4. QSAR for anti-HIV activity of HEPT derivatives.
Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 6-substituted acyclouridine derivatives and their anti-HIV-1 activity.
Tanaka H; Baba M; Ubasawa M; Takashima H; Sekiya K; Nitta I; Walker RT; De Clereq E; Miyasaka T
Nucleic Acids Symp Ser; 1990; (22):127-8. PubMed ID: 2101894
[TBL] [Abstract][Full Text] [Related]
6. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
Esnouf R; Ren J; Ross C; Jones Y; Stammers D; Stuart D
Nat Struct Biol; 1995 Apr; 2(4):303-8. PubMed ID: 7540935
[TBL] [Abstract][Full Text] [Related]
8. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Walker RT; Mori S
Mol Pharmacol; 1991 Jun; 39(6):805-10. PubMed ID: 1711148
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Balzarini J; Karlsson A; De Clercq E
Mol Pharmacol; 1993 Oct; 44(4):694-701. PubMed ID: 7694068
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].
Mitsuya H
Nihon Rinsho; 1991 Sep; 49(9):2062-9. PubMed ID: 1720470
[No Abstract] [Full Text] [Related]
11. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
Gayen S; Debnath B; Samanta S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
[TBL] [Abstract][Full Text] [Related]
12. Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
Puig-de-la-Bellacasa R; Giménez L; Pettersson S; Pascual R; Gonzalo E; Esté JA; Clotet B; Borrell JI; Teixidó J
Eur J Med Chem; 2012 Aug; 54():159-74. PubMed ID: 22652226
[TBL] [Abstract][Full Text] [Related]
13. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
[TBL] [Abstract][Full Text] [Related]
14. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.
Hopkins AL; Ren J; Esnouf RM; Willcox BE; Jones EY; Ross C; Miyasaka T; Walker RT; Tanaka H; Stammers DK; Stuart DI
J Med Chem; 1996 Apr; 39(8):1589-600. PubMed ID: 8648598
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
Velázquez S; Alvarez R; San-Félix A; Jimeno ML; De Clercq E; Balzarini J; Camarasa MJ
J Med Chem; 1995 May; 38(10):1641-9. PubMed ID: 7538589
[TBL] [Abstract][Full Text] [Related]
16. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
17. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
Douali L; Villemin D; Zyad A; Cherqaoui D
Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
[TBL] [Abstract][Full Text] [Related]
18. Specific HIV-1 reverse transcriptase inhibitors.
Debyser Z; Pauwels R; Andries K; De Clercq E
J Enzyme Inhib; 1992; 6(1):47-53. PubMed ID: 1285302
[No Abstract] [Full Text] [Related]
19. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Miyasaka T; Tanaka H; Baba M; Hayakawa H; Walker RT; Balzarini J; De Clercq E
J Med Chem; 1989 Dec; 32(12):2507-9. PubMed ID: 2479745
[No Abstract] [Full Text] [Related]
20. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
